Academic Conference
Heer Medical Exhibits Equipment at the Shanxi Provincial Pathology Annual Conference, Receiving Expert Recognition
In July 2023, Heer Medical exhibited the fully automatic multispectral cellular image analysis system at the 41st Shanxi Provincial Pathology Annual Conference, showcasing DNA quantitative detection, p16/Ki-67 dual staining, and HPV E6/E7 protein detection technologies, receiving high recognition from experts.
From July 28 to 30, 2023, the "41st Shanxi Pathology Annual Conference of the Shanxi Medical Association Pathology Professional Committee" was successfully held at the Taiyuan Garden International Hotel. The event was jointly organized by the Shanxi Medical Association Pathology Professional Committee, the Pathology Branch of the Shanxi Medical Doctor Association, the Tumor Pathology Professional Committee of the Shanxi Anti-Cancer Association, and the Shanxi Provincial Health Commission Pathology Quality Control Center; co-organized by the Pathology Technology Study Group of the Shanxi Medical Association Pathology Professional Committee; and hosted by the Shanxi Hospital of the Chinese Academy of Medical Sciences Cancer Hospital.
The conference covered: tissue pathological diagnosis, cytopathological diagnosis, pathological technology, molecular pathology, and difficult case slide reading. The conference adhered to the principles of advancement, academia, and practicality, primarily focusing on academic discussions of hot and difficult issues in various areas of pathological diagnosis.
Heer Medical exhibited with its fully automatic multispectral cellular image analysis system, showcasing DNA quantitative detection technology, p16/Ki-67 dual staining detection technology, and HPV E6/E7 protein detection technology. The booth attracted numerous doctors and visitors, and received customer attention and recognition.
As Heer Medical's product line continues to be refined, the cytopathology line comprehensively covers DNA quantification and AI cell morphology assisted diagnosis technology, providing a full-process solution for primary cervical cancer screening; the immunohistochemistry product line's HPV E6/E7 protein and p16/Ki-67 dual staining provide a full-process intelligent solution for detecting transforming infections.
Contributing Heer's strength toward the early elimination of cervical cancer — Heer Medical looks forward to building a better future together with you!